|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Routine use of the Ion Torrent AmpliSeq? Cancer Hotspot Panel for identification of clinically actionable somatic mutations显示文摘 | Gregory J. Tsongalis Jason D. Peterson Francine B. de Abreu Christopher D. Tunkey Torrey L. Gallagher Linda D. Strausbaugh Wendy A. Wells Christopher I. Amos | 2014 | Clinical Chemistry and Laboratory Medicine2014，，5： | 1 |
| 2 | Prevention and treatment of postm- enopausal osteoporosis显示文摘 | Harsha T Christopher Gallagher | 2014 | The Journal of Steroid Biochemistry and Molecular Biology2014，142，65： | 1 |
| 3 | Vitamin D and Aging显示文摘 | J. Christopher Gallagher | 2013 | Endocrinology and Metabolism Clinics of North America2013，，2： | 1 |
| 4 | Prevention and treatment of postmenopausal osteoporosis显示文摘 | Sri Harsha Tella J. Christopher Gallagher | 2013 | Journal of Steroid Biochemistry and Molecular Biology2013，，： | 1 |
| 5 | Fission track analysis andits application to geological problems显示文摘 | Gallagher K Brown R Christopher J | 1998 | Annual Review ofEarth and Planetary Sciences1998，26，： | 1 |
| 6 | The Effects of Anxiety and Depressive Symptoms on Daily Positive Emotion Regulation显示文摘 | Jenna R. Carl Christopher P. Fairholme Matthew W. Gallagher Johanna Thompson-Hollands David H. Barlow | 2014 | Journal of Psychopathology and Behavioral Assessment2014，，2： | 1 |
| 7 | Fission track analysis and its application to geological problems显示文摘 | Gallagher K Brown R Christopher J | 1998 | Annu Rev Earth Planet Sci1998，26，： | 1 |
| 8 | Intravitreal Triamcinolone Acetonide Injection for Treatment of Refractory Diabetic Macular Edema显示文摘 | Taygan Yilmaz Christopher D. Weaver Micheal J. Gallagher Miguel Cordero-Coma Rene A. Cervantes-Castaneda Dino Klisovic Alejandro J. Lavaque Robin J. Larson | 2009 | Ophthalmology2009，，5： | 1 |
| 9 | A Randomized, Controlled Trial on Dexmedetomidine for Providing Adequate Sedation and Hemodynamic Control for Awake, Diagnostic Transesophageal Echocardiography显示文摘 | Lebron Cooper Keith Candiotti Christopher Gallagher Ernesto Grenier Kristopher L. Arheart Michael E. Barron | 2011 | Journal of Cardiothoracic and Vascular Anesthesia2011，，2： | 1 |
| 10 | Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women显示文摘 | Robert Lindsay J. Christopher Gallagher Michael Kleerekoper James H. Pickar | | 0，，： | 1 |
| 11 | Functional imaging of ‘theory of mind显示文摘 | Gallagher Helen L Frith Christopher D | | 0，，02： | 1 |
| 12 | Virtual reality training for the operating room and cardiac catheterisation laboratory显示文摘 | Anthony G Gallagher Christopher U Cates | 2004 | The Lancet . 2004 (9444)2004，，9444： | 1 |
| 13 | The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know显示文摘 | A. Catharine Ross JoAnn E. Manson Steven A. Abrams John F. Aloia Patsy M. Brannon Steven K. Clinton Ramon A. Durazo-Arvizu J. Christopher Gallagher Richard L. Gallo Glenville Jones Christopher S. Kovacs Susan T. Mayne Clifford J. Rosen Sue A. Shapses | 2011 | The Journal of Clinical Endocrinology & Metabolism2011，，： | 1 |
| 14 | Functional Imaging of 'Theory of Mind' 显示文摘 | Helen L Gallagher Christopher D Firth | 2003 | Trends in Cognitive Sciences2003，7，2： | 1 |
| 15 | Medium-term mortality after hip fractures and COVID-19:A prospective multicentre UK study显示文摘Purpose:The COVID-19 pandemic has caused 1.4 million deaths globally and is associated with a 3-4 times increase in 30-day mortality after a fragility hip fracture with concurrent COVID-19 infection.Typically,death from COVID-19 infection occurs between 15 and 22 days after the onset of symptoms,but this period can extend up to 8 weeks.This study aimed to assess the impact of concurrent COVID-19 infection on 120-day mortality after a fragility hip fracture.Methods:A multi-centre prospective study across 10 hospitals treating 8%of the annual burden of hip fractures in England between 1st March and 30th April,2020 was performed.Patients whose surgical treatment was payable through the National Health Service Best Practice Tariff mechanism for'fragility hip fractures'were included in the study.Patients'120-day mortality was assessed relative to their perioperative COVID-19 status.Statistical analysis was performed using SPSS version 27.Results:A total of 746 patients were included in this study,of which 87(11.7%)were COVID-19 positive.Mortality rates at 30-and 120-day were significantly higher for COVID-19 positive patients relative to COVID-19 negative patients(p<0.001).However,mortality rates between 31 and 120-day were not significantly different(p=0.107),16.1%and 9.4%respectively for COVID-19 positive and negative patients,odds ratio 1.855(95%CI 0.865-3.978).Conclusion:Hip fracture patients with concurrent COVID-19 infection,provided that they are alive at day-31 after injury,have no significant difference in 120-day mortality.Despite the growing awareness and concern of 'long-COVID'and its widespread prevalence,this does not appear to increase mediumterm mortality rates after a hip fracture. | Gareth Chan Ashish Narang Arash Aframian Zaid Ali Joseph Bridgeman Alastair Carr Laura Chapman Henry Goodier Catrin Morgan Chang Park Sarah Sexton Kapil Sugand Thomas Walton Michael Wilson Ajay Belgaumkar Kieran Gallagher Koushik Ghosh Charles Gibbons Joshua Jacob Andrew Keightley Zuhair Nawaz Khaled Sarraf Christopher Wakeling William Kieffer Benedict Rogers | 2022 | Chinese Journal of Traumatology2022，25，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员